China's Xiwang in advanced talks to acquire MuscleTech owner: sources
By Lauren Hirsch and Denny Thomas
(Reuters) - Chinese food and industrial conglomerate Xiwang Group Company Ltd is in advanced talks to buy Iovate Health Sciences International Inc, the Canadian owner of nutrition supplement MuscleTech, according to people familiar with the matter.
Iovate is the latest Canadian vitamin maker to attract Chinese interest, as growing awareness of health and wellness issues among Chinese consumers, combined with a lack of confidence in China's safety standards, spurs the country's companies to look overseas for nutritional supplement assets.
Canada has some of the most stringent safety standards for nutrition supplements in the world, making its companies coveted among peers for the popularity of their brands. Canadian vitamin maker Jamieson Laboratories, owned by private equity firm CCMP Capital Advisors LP, has also attracted interest from Chinese buyers, Reuters previously reported.
Xiwang, which is controlled by Chinese Communist Party insider Wang Yong, has so far prevailed in an auction for Iovate and is negotiating a price of more than $700 million, the people said this week.
Privately held Iovate has around $70 million in 12-month earnings before interest, tax, and depreciation, the people added, asking not to be identified because the negotiations are confidential.
There is no certainty that Xiwang will reach an agreement with Iovate, or that any deal would clear all regulatory hurdles, the people cautioned.
Xiwang and Iovate did not immediately respond to requests for comment.
Xiwang's bid follows a string of Chinese acquisition efforts overseas, after the government encouraged outbound corporate investment in light of slowing domestic growth. Last year, Chinese companies scored a record $104 billion of foreign deals, nearly double that of 2014, according to Thomson Reuters data. Continued...